CDSCO

Generic medicines in India face scrutiny as the CDSCO grapples with substandard drugs, lack of human resources, state data blackouts, and MSME violations.

India's pharmaceutical industry faces scrutiny as contaminated drugs cause public health concerns. Calls for stricter regulations and a comprehensive overhaul of the regulatory system grow louder.